// November 28, 2023
FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards
This year has seen a flurry of activity by the U.S.
This year has seen a flurry of activity by the U.S.
USP’s Naiffer Romero has teamed up with researchers at LHASA Limited, AstraZeneca, Sai Life S
This summer, a wave of regulatory activity on nitrosamines has taken place, with agencies fro
Nitrosamine impurities in pharmaceutical products have been making major headlines recently, as t